Literature DB >> 2376583

Radiosequence analysis of the human progestin receptor charged with [3H]promegestone. A comparison with the glucocorticoid receptor.

P E Strömstedt1, A Berkenstam, H Jörnvall, J A Gustafsson, J Carlstedt-Duke.   

Abstract

Partially purified preparations of the human progestin receptor and the human and rat glucocorticoid receptor proteins were covalently charged with the synthetic progestin, [3H]promegestone, by photoaffinity labeling. After labeling, the denaturated protein was cleaved and the mixture of peptides subjected to radiosequence analysis as previously described for the rat glucocorticoid receptor protein (Carlstedt-Duke, J., Strömstedt, P.-E., Persson, B., Cederlund, E., Gustafsson, J.-A., and Jörnvall, H. (1988) J. Biol. Chem. 263, 6842-6846). The radioactivity labels identified, corresponded to Met-759 and Met-909 after photoaffinity labeling of the human progestin receptor, and Met-622 and Cys-754 after labeling of the rat glucocorticoid receptor. The residues labeled in the glucocorticoid receptor are the same as those previously reported to bind triamcinolone actonide. The corresponding residues were also labeled in the human glucocorticoid receptor. Met-759 of the progestin receptor and Met-622 of the rat glucocorticoid receptor are positioned within a segment with an overall high degree of sequence similarity and are equivalent. However, Met-909 (progestin receptor) and Cys-754 (glucocorticoid receptor) do not occur within equivalent segments of the two proteins. Thus, although the two classes of steroid hormone share a common structure within the A-ring, there are subtle differences in their interaction with the two separate receptor proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Aldosterone antagonists destabilize the mineralocorticosteroid receptor.

Authors:  B Couette; M Lombes; E E Baulieu; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

Review 2.  Steroid hormone receptors and their regulation by phosphorylation.

Authors:  N L Weigel
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  Three-dimensional model for the hormone binding domains of steroid receptors.

Authors:  R A Goldstein; J A Katzenellenbogen; Z A Luthey-Schulten; D A Seielstad; P G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

4.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

5.  Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide.

Authors:  H Li; Z Yao; B Degenhardt; G Teper; V Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

6.  Definition of a novel ligand binding domain of a nuclear bHLH receptor: co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor.

Authors:  M L Whitelaw; M Göttlicher; J A Gustafsson; L Poellinger
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

7.  Theory of partial agonist activity of steroid hormones.

Authors:  Carson C Chow; Karen M Ong; Benjamin Kagan; S Stoney Simons
Journal:  AIMS Mol Sci       Date:  2015
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.